Inogen Inc (INGN)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $147.95M
Last updated: Nov 17, 2026 at 11:04 AM ET
Inogen Inc (INGN) Stock Forecast
Analysts expect Inogen (INGN) to earn -$0.29 per share in the fiscal year ending Dec 31, 2026, on revenue of $311.30M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.36.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates fall 1.1%.
- Fiscal year ending Dec 31, 2026
- -$0.29
- EPS consensus, revenue $311.30M
- Fiscal year ending Dec 31, 2027
- -$0.36
- EPS consensus, revenue $307.95M
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.29 | -$0.29 to -$0.29 | 1 | $311.30M | $299.20M to $323.40M | 2 |
| Dec 31, 2027 | -$0.36 | -$0.36 to -$0.36 | 1 | $307.95M | $307.90M to $308.00M | 2 |
Quarterly Estimates
The EPS consensus falls from -$0.18 for the quarter ending Dec 31, 2026 to -$0.23 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.18 | -$0.19 to -$0.17 | 4 | $85.68M | $81.14M to $89.46M | 4 |
| Mar 31, 2027 | -$0.23 | -$0.25 to -$0.20 | 2 | N/A | N/A | 0 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 4 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 1 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.28.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.29 | -$0.28 | -$0.28 | -$0.28 | -$0.28 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.36 | -$0.16 | -$0.16 | -$0.16 | -$0.16 | N/A |
| Quarter ending Mar 31, 2027 | -$0.23 | -$0.21 | -$0.21 | -$0.21 | -$0.19 | N/A |
Frequently Asked Questions About INGN
What is the INGN stock forecast?
Consensus analyst estimates put Inogen's EPS at -$0.29 for the fiscal year ending Dec 31, 2026, on revenue of $311.30M.
What EPS do analysts expect from INGN next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.29, with estimates from -$0.29 to -$0.29 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.36, with estimates from -$0.36 to -$0.36 from 1 analyst.
What revenue do analysts expect from Inogen next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $311.30M, with estimates from $299.20M to $323.40M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $307.95M, with estimates from $307.90M to $308.00M.
How many analysts cover INGN?
1 analyst estimates EPS for Inogen for the fiscal year ending Dec 31, 2026.
INGN pages: Overview, Earnings, Forecast, Financials, Competitors, Government Contracts